Cover Image
市場調查報告書

Aphios Corporation - 產品平台分析

Aphios Corporation - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 251642
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
Aphios Corporation - 產品平台分析 Aphios Corporation - Product Pipeline Review - 2016
出版日期: 2016年02月24日 內容資訊: 英文 53 Pages
簡介

Aphios Corporation正在開發治療某種特定傳染病及癌症、中樞神經系統障礙用的技術性平台及高效果治療藥。

本報告提供Aphios Corporation 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Aphios Corporation 基本資料

Aphios Corporation 概要

  • 主要資訊
  • 企業資料

Aphios Corporation :R&D概要

  • 主要的治療範圍

Aphios Corporation :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Aphios Corporation :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Aphios Corporation :藥物簡介

  • APH-0703
  • APH-0812
  • AMPI-109
  • APH-0201
  • APH-0701
  • APH-0907
  • APH-0911
  • APH-0912
  • Asterias
  • camptothecin nanosomal
  • dronabinol
  • Frondoside A
  • HIV/AIDS Therapeutic Vaccine
  • Hypericin
  • Marinus
  • paclitaxel nanosomal
  • paclitaxel phospholipid nanosomal
  • Sperol
  • APH-0202
  • APH-0804
  • APH-1305
  • APP-0205
  • APP-069
  • APP-309
  • APP-401

Aphios Corporation :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aphios Corporation :最近的開發平台趨勢

Aphios Corporation :暫停中的計劃

Aphios Corporation :總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07952CDB

Summary

Global Markets Direct's, 'Aphios Corporation - Product Pipeline Review - 2016', provides an overview of the Aphios Corporation's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Aphios Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Aphios Corporation
  • The report provides overview of Aphios Corporation including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Aphios Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Aphios Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Aphios Corporation's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Aphios Corporation
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Aphios Corporation's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aphios Corporation Snapshot
    • Aphios Corporation Overview
    • Key Information
    • Key Facts
  • Aphios Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Aphios Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Aphios Corporation - Pipeline Products Glance
    • Aphios Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Aphios Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Aphios Corporation - Drug Profiles
    • APH-0812
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0703
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AMPI-109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0701
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0907
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0911
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0912
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-1201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-1305
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • camptothecin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dronabinol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hypericin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • paclitaxel
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • paclitaxel phospholipid
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Sperol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0202
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-0804
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APH-1403
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APP-0205
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APP-069
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APP-309
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APP-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Marinus
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aphios Corporation - Pipeline Analysis
    • Aphios Corporation - Pipeline Products by Target
    • Aphios Corporation - Pipeline Products by Route of Administration
    • Aphios Corporation - Pipeline Products by Molecule Type
    • Aphios Corporation - Pipeline Products by Mechanism of Action
  • Aphios Corporation - Recent Pipeline Updates
  • Aphios Corporation - Dormant Projects
  • Aphios Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aphios Corporation, Key Information
  • Aphios Corporation, Key Facts
  • Aphios Corporation - Pipeline by Indication, 2016
  • Aphios Corporation - Pipeline by Stage of Development, 2016
  • Aphios Corporation - Monotherapy Products in Pipeline, 2016
  • Aphios Corporation - Partnered Products in Pipeline, 2016
  • Aphios Corporation - Partnered Products/ Combination Treatment Modalities, 2016
  • Aphios Corporation - Phase II, 2016
  • Aphios Corporation - Phase I, 2016
  • Aphios Corporation - Preclinical, 2016
  • Aphios Corporation - Discovery, 2016
  • Aphios Corporation - Pipeline by Target, 2016
  • Aphios Corporation - Pipeline by Route of Administration, 2016
  • Aphios Corporation - Pipeline by Molecule Type, 2016
  • Aphios Corporation - Pipeline Products by Mechanism of Action, 2016
  • Aphios Corporation - Recent Pipeline Updates, 2016
  • Aphios Corporation - Dormant Developmental Projects,2016

List of Figures

  • Aphios Corporation - Pipeline by Top 10 Indication, 2016
  • Aphios Corporation - Pipeline by Stage of Development, 2016
  • Aphios Corporation - Monotherapy Products in Pipeline, 2016
  • Aphios Corporation - Pipeline by Top 10 Target, 2016
  • Aphios Corporation - Pipeline by Route of Administration, 2016
  • Aphios Corporation - Pipeline by Molecule Type, 2016
  • Aphios Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top